Inloggad som:
RITZ
Är du som patient intresserad av mer information om en studie, kontakta din behandlande läkare.
RITZ
Phase 3, interventional, multicentre, open label, randomized study comparing rituximab plus zanubrutinib to rituximab monotherapy in previously untreated, symptomatic splenic marginal zone lymphoma
Phase 3, interventional, multicentre, open label, randomized study comparing rituximab plus zanubrutinib to rituximab monotherapy in previously untreated, symptomatic splenic marginal zone lymphoma
Karolinska Universitetssjukhuset / Hematologisk vård
Mer information om studien för vårdgivare
Studien ändrades senast: (2025-11-25)